Navigation Links
New genital gel could empower women against the AIDS epidemic

John Moore of Cornell University in New York and his colleagues are enthused by their finding of a new viral blocker that prevents the virus from burying into human cells. This blocker, in its initial testing in monkeys was found to curb sexual transmission of HIV between monkeys. The new study has backed the belief that microbicides - chemicals that hobble viruses - could act as shields against HIV. This or other microbicides, applied in cream form to the vagina or rectum could// save the lives of several women who are not able to protect themselves by monogamy or by using condoms.

Researchers are investigating around 60 potential microbicides that thwart HIV in a variety of ways. Carraguard, a microbicide extracted from seaweeds is already into phase III clinical trials in Southern Africa. Carraguard gums up the surface of virus and vaginal cells to create a physical barrier against infection. Other products being tested, such as Buffergel, instead increase acidity to oust the virus. However, some of the other candidates in this category like the spermicide nonoxynol-9 have been found to increase HIV infection as attack and weaken vaginal cell walls, as well as the target virus.

In the new study, researchers used a human antibody called b12 that binds an HIV coat protein and stops it latching onto cells. They found that when this product was used in monkeys two hours before sex, it prevented infection in 9 out of 12 monkeys, while 12 out of 13 monkeys were infected without the antibody. This antibody, unlike certain other microbicides targets only the HIV virus and does not affect healthy cells.


'"/>




Page: 1

Related medicine news :

1. Kids with Congenital Heart Disease Found To Have Low I.Q Levels
2. Infection in pregnancy can lead to congenital eye defects
3. Enzyme Responsible For Congenital Blindness
4. Exercise to childrens with congenital disease beneficial
5. Fungal toxins infected corn the reason for congenital defects
6. Anti-Parasitic Drugs Useful in Reducing Damages of Congenital Toxoplasmosis
7. Gene Therapy May Help Restore Sight In Congenital blindness
8. NSAIDs In First trimester Linked To Congenital Anomalies In Babies
9. Competitive women cyclists experience reduced genital sensation
10. Babies With Congenital Heart Defects Live Longer, Study Shows
11. Virus Level could Predict Cervical Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with ... to schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing ... directory will bring more Six Month Smiles patients to their providers.” , Each month, ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol ... global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces ... 2017 to June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits ...
(Date:7/26/2017)... ... 26, 2017 , ... BioPlus Specialty Pharmacy (BioPlus), ... of the HCV Treatment Path app (version 4.4.0) to keep health care providers ... All of the latest HCV medications are included in this app, including Vosevi™ ...
(Date:7/25/2017)... , ... July 25, 2017 , ... Summers in Palm ... the air conditioner — think homemade gourmet ice cream, sparkling pools, and mile-high fun. ... shop featuring fun mugs, journals, and other must-have knick knacks. Ice cream and sorbet ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance ... services to communities across North Carolina, is launching a charity event in conjunction ... support for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... IBM (NYSE: IBM ) has been recognized as a ... for the fourth year in a row. 1 ... the Leaders quadrant have the highest scores for their Ability ... Leaders quadrant has the market share, credibility, and marketing and ... These vendors demonstrate a clear understanding of market needs; they ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) announced today that ... before the market opens on Thursday, July 27, 2017. ... host a teleconference on Thursday, July 27, 2017, at ... dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) released ... , M.D., following today,s Institute for Clinical and Economic Review,s ... on the effectiveness and value of abuse-deterrent formulations (ADF) of ... policy roundtable at the meeting. ... material cost benefit to the use of abuse-deterrent formulations (ADF) ...
Breaking Medicine Technology: